Best U.S. Cannabis Penny Stocks to Trade Now With Rescheduling Momentum

Industry Overview - The U.S. cannabis market is projected to approach $45 billion in sales by 2025, with analysts expecting double-digit annual growth through 2030 [1] - More states are supporting recreational cannabis access, and medical adoption is expanding nationwide [1] - Recent news indicates that President Trump may issue an executive order to reclassify cannabis from Schedule I to Schedule III, which could ease restrictions on research, taxation, and investment [1] Trading Insights - Traders are advised to adopt a disciplined process, utilizing technical analysis to identify momentum before volume surges [2] - Key indicators include moving-average curls, trendline breaks, and heavy bid stacking near support [2] - Position sizing should remain small due to the high volatility associated with penny stocks [2] Company Highlights AYR Wellness Inc. (AYRWF) - AYR Wellness is a multi-state cannabis operator based in Miami, Florida, focusing on medical and adult-use cannabis [6] - The company has a vertically integrated structure with cultivation, processing, and retail operations across several states [6] - Financially, AYR reported stagnant revenue year-over-year, with losses expanding due to increased operational costs and competitive pricing pressure [8] FLUENT (CNTMF) - FLUENT is a vertically integrated cannabis company headquartered in Tampa, Florida, with operations in cultivation, manufacturing, and retail [9] - The company has a significant presence in Florida, New York, and Pennsylvania, operating over thirty dispensaries [9] - Recent financial results showed nearly flat revenue year-over-year, with margins compressed due to pricing mix and processing inefficiencies [10] Curaleaf Holdings Inc. (CURLF) - Curaleaf is one of the largest cannabis retailers in the U.S., with about 150 retail locations and a diverse product offering [12] - The company has seen revenue growth as new adult-use markets opened, although profitability remains uncertain due to high compliance and operational costs [13] - Curaleaf's extensive retail network provides a competitive advantage, positioning the company well for future growth as federal reforms progress [13] Market Sentiment - The cannabis trade in December focuses on positioning rather than certainty, with stocks like AYRWF, CNTMF, and CURLF providing exposure to real dispensaries and revenue [14] - Improving state access and consumer demand could lead to a stronger industry outlook in 2026 [14]